Published in Curr Opin Immunol on April 01, 1999
Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes. J Exp Med (1990) 5.04
Parasitologic and clinical human response to immunoglobulin administration in falciparum malaria. Am J Trop Med Hyg (1991) 4.16
Replicative and cytopathic potential of HTLV-III/LAV with sor gene deletions. Science (1986) 4.04
Vector density gradients and the epidemiology of urban malaria in Dakar, Senegal. Am J Trop Med Hyg (1992) 3.71
Plasmodium falciparum malaria: evidence for an isotype imbalance which may be responsible for delayed acquisition of protective immunity. Infect Immun (1992) 3.42
Mechanisms underlying the monocyte-mediated antibody-dependent killing of Plasmodium falciparum asexual blood stages. J Exp Med (1995) 3.36
Merozoite surface protein-3: a malaria protein inducing antibodies that promote Plasmodium falciparum killing by cooperation with blood monocytes. Blood (1994) 3.05
Fast emergence of Plasmodium falciparum resistance to halofantrine. Lancet (1993) 3.03
Protection against Plasmodium falciparum malaria in chimpanzees by immunization with the conserved pre-erythrocytic liver-stage antigen 3. Nat Med (2000) 2.70
Malaria: even more chronic in nature than previously thought; evidence for subpatent parasitaemia detectable by the polymerase chain reaction. Trans R Soc Trop Med Hyg (1996) 2.65
Human antibodies to the 19kDa C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 inhibit parasite growth in vitro. Parasite Immunol (1999) 2.39
YOPRO-1 permits cytofluorometric analysis of programmed cell death (apoptosis) without interfering with cell viability. J Immunol Methods (1995) 2.25
The neurotrophic factor neuroleukin is 90% homologous with phosphohexose isomerase. Nature (1988) 2.16
Levels of antibodies to Plasmodium falciparum sporozoite surface antigens reflect malaria transmission rates and are persistent in the absence of reinfection. Infect Immun (1986) 2.14
A new function for platelets: IgE-dependent killing of schistosomes. Nature (1983) 2.11
A liver-stage-specific antigen of Plasmodium falciparum characterized by gene cloning. Nature (1987) 2.02
The glutamate-rich protein (GLURP) of Plasmodium falciparum is a target for antibody-dependent monocyte-mediated inhibition of parasite growth in vitro. Infect Immun (1998) 2.00
Pattern of immunoglobulin isotype response to Plasmodium falciparum blood-stage antigens in individuals living in a holoendemic area of Senegal (Dielmo, west Africa). Am J Trop Med Hyg (1996) 1.98
Green fluorescent protein as a new expression marker in mycobacteria. Mol Microbiol (1995) 1.97
On the evolution of programmed cell death: apoptosis of the unicellular eukaryote Leishmania major involves cysteine proteinase activation and mitochondrion permeabilization. Cell Death Differ (2002) 1.90
Effect of antibodies to recombinant and synthetic peptides on P. falciparum sporozoites in vitro. Science (1986) 1.81
Rapid turnover of Plasmodium falciparum populations in asymptomatic individuals living in a high transmission area. Am J Trop Med Hyg (1996) 1.76
Cooperation between antibodies and monocytes that inhibit in vitro proliferation of Plasmodium falciparum. Infect Immun (1983) 1.74
Phase-locking of magnetic vortices mediated by antivortices. Nat Nanotechnol (2009) 1.71
Programmed cell death in mature erythrocytes: a model for investigating death effector pathways operating in the absence of mitochondria. Cell Death Differ (2001) 1.69
Cytophilic immunoglobulin responses to Plasmodium falciparum glutamate-rich protein are correlated with protection against clinical malaria in Dielmo, Senegal. Infect Immun (2000) 1.68
Epitope-specific protective immunogenicity of chemically synthesized 13-, 18-, and 23-residue peptide fragments of streptococcal M protein. Proc Natl Acad Sci U S A (1984) 1.67
Cellular and molecular mechanisms of senescent erythrocyte phagocytosis by macrophages. A review. Biochimie (1998) 1.62
Effector cells involved in nonspecific and antibody-dependent mechanisms directed against Plasmodium falciparum blood stages in vitro. Infect Immun (1989) 1.61
Complete development of hepatic stages of Plasmodium falciparum in vitro. Science (1985) 1.58
A novel secreted cyclophilin-like protein (SCYLP). J Biol Chem (1991) 1.52
Natural antibody response to Plasmodium falciparum Exp-1, MSP-3 and GLURP long synthetic peptides and association with protection. Parasite Immunol (2004) 1.51
Human malaria in immunocompromised mice: an in vivo model to study defense mechanisms against Plasmodium falciparum. J Exp Med (2000) 1.50
Epidemiological correlation between levels of antibodies promoting merozoite phagocytosis of Plasmodium falciparum and malaria-immune status. Infect Immun (1987) 1.48
Analysis of the Mycobacterium tuberculosis 85A antigen promoter region. J Bacteriol (1995) 1.48
Enhanced Plasmodium falciparum merozoite phagocytosis by monocytes from immune individuals. Infect Immun (1982) 1.46
The predictive value of cardiac troponin T measurements in subjects on regular haemodialysis. Nephrol Dial Transplant (1999) 1.43
Evaluation under field conditions of the colourimetric DELI-microtest for the assessment of Plasmodium falciparum drug resistance. Trans R Soc Trop Med Hyg (2001) 1.42
Early divergence in lymphoid tissue apoptosis between pathogenic and nonpathogenic simian immunodeficiency virus infections of nonhuman primates. J Virol (2007) 1.39
Lipopeptide immunization without adjuvant induces potent and long-lasting B, T helper, and cytotoxic T lymphocyte responses against a malaria liver stage antigen in mice and chimpanzees. Eur J Immunol (1997) 1.39
Malaria morbidity among children exposed to low seasonal transmission in Dakar, Senegal and its implications for malaria control in tropical Africa. Am J Trop Med Hyg (1993) 1.34
Cultivation of the liver forms of Plasmodium vivax in human hepatocytes. Nature (1984) 1.33
The receptor for IgE on blood platelets. Eur J Immunol (1986) 1.32
Large microwave generation from current-driven magnetic vortex oscillators in magnetic tunnel junctions. Nat Commun (2010) 1.32
Evaluation of an in vitro assay aimed at measuring protective antibodies against sporozoites. Bull World Health Organ (1990) 1.30
Species- and stage-specific antigens in exoerythrocytic stages of Plasmodium falciparum. Am J Trop Med Hyg (1984) 1.30
Adenovirus-mediated transfer of viral IL-10 gene inhibits murine collagen-induced arthritis. J Immunol (1998) 1.29
Impaired cell-mediated immunity in Plasmodium falciparum-infected patients with high-parasitemia and cerebral malaria. Clin Immunol Immunopathol (1983) 1.26
Multi-drug resistant falciparum malaria in Cameroon in 1987-1988. I. Stable figures of prevalence of chloroquine- and quinine-resistant isolates in the original foci. Am J Trop Med Hyg (1992) 1.26
Epitope specific immunity elicited by a synthetic streptococcal antigen without carrier or adjuvant. Biochem Biophys Res Commun (1983) 1.23
Antibodies in falciparum malaria: what matters most, quantity or quality? Mem Inst Oswaldo Cruz (1992) 1.23
Assessment of renal function in clinical practice at the bedside of burn patients. Br J Clin Pharmacol (2006) 1.21
From AIDS to parasite infection: pathogen-mediated subversion of programmed cell death as a mechanism for immune dysregulation. Immunol Rev (1994) 1.19
A novel Plasmodium falciparum sporozoite and liver stage antigen (SALSA) defines major B, T helper, and CTL epitopes. J Immunol (1996) 1.16
A novel merozoite surface antigen of Plasmodium falciparum (MSP-3) identified by cellular-antibody cooperative mechanism antigenicity and biological activity of antibodies. Mem Inst Oswaldo Cruz (1994) 1.16
Trypanosoma cruzi infection inhibited by peptides modeled from a fibronectin cell attachment domain. Science (1986) 1.15
Induction of a protective antibody-dependent response against toxoplasmosis by in vitro excreted/secreted antigens from tachyzoites of Toxoplasma gondii. Parasite Immunol (1988) 1.15
Immunization of Saimiri sciureus monkeys with Plasmodium falciparum merozoite surface protein-3 and glutamate-rich protein suggests that protection is related to antibody levels. Scand J Immunol (2004) 1.14
TGF-beta in intestinal lymphoid organs contributes to the death of armed effector CD8 T cells and is associated with the absence of virus containment in rhesus macaques infected with the simian immunodeficiency virus. Cell Death Differ (2007) 1.14
Multiepitopic B- and T-cell responses induced in humans by a human immunodeficiency virus type 1 lipopeptide vaccine. J Virol (2000) 1.14
Mycobacterium bovis Bacillus Calmette Guérin infection prevents apoptosis of resting human monocytes. Eur J Immunol (1997) 1.14
[Immuno-electro-diffusion on cellulose acetate membrane for serological testing in human malaria (author's transl)]. Pathol Biol (Paris) (1978) 1.14
Molecular cloning and sequence analysis of bovine lactotransferrin. Eur J Biochem (1991) 1.13
Calciseptine, a peptide isolated from black mamba venom, is a specific blocker of the L-type calcium channel. Proc Natl Acad Sci U S A (1991) 1.13
Parasite-derived mitogenic activity for human T cells in Plasmodium falciparum continuous cultures. Infect Immun (1981) 1.13
Antibody-dependent ingestion of P. falciparum merozoites by human blood monocytes. Parasite Immunol (1983) 1.12
Apoptosis in SIV infection. Cell Death Differ (2005) 1.12
Premunition against Plasmodium falciparum in a malaria hyperendemic village in Myanmar. Trans R Soc Trop Med Hyg (2001) 1.11
The interferon compartment of the immune response in human malaria: II. Presence of serum-interferon gamma following the acute attack. J Interferon Res (1985) 1.11
Antagonism of chloroquine with other antimalarials. Trans R Soc Trop Med Hyg (1988) 1.10
Protection against malaria induced by irradiated sporozoites. Lancet (1990) 1.10
Inhibition of lipoprotein lipase activity by synthetic peptides of apolipoprotein C-III. J Lipid Res (1992) 1.10
Leiurotoxin I (scyllatoxin), a peptide ligand for Ca2(+)-activated K+ channels. Chemical synthesis, radiolabeling, and receptor characterization. J Biol Chem (1990) 1.10
Selection of glutamate-rich protein long synthetic peptides for vaccine development: antigenicity and relationship with clinical protection and immunogenicity. Infect Immun (2001) 1.10
Plasmodium falciparum sporozoite invasion is inhibited by naturally acquired or experimentally induced polyclonal antibodies to the STARP antigen. Eur J Immunol (1997) 1.10
Immunization of mice with lipopeptides bypasses the prerequisite for adjuvant. Immune response of BALB/c mice to human immunodeficiency virus envelope glycoprotein. J Immunol (1992) 1.10
Distinct cycling CD4(+)- and CD8(+)-T-cell profiles during the asymptomatic phase of simian immunodeficiency virus SIVmac251 infection in rhesus macaques. J Virol (2003) 1.09
Identification of a major B-cell epitope of the Plasmodium falciparum glutamate-rich protein (GLURP), targeted by human antibodies mediating parasite killing. Vaccine (2000) 1.09
Molecular structure of a Toxoplasma gondii dense granule antigen (GRA 5) associated with the parasitophorous vacuole membrane. Mol Biochem Parasitol (1993) 1.09
Infection of mice lacking interleukin-7 (IL-7) reveals an unexpected role for IL-7 in the development of the parasite Schistosoma mansoni. Infect Immun (1999) 1.08
Caspase-dependent and -independent T-cell death pathways in pathogenic simian immunodeficiency virus infection: relationship to disease progression. Cell Death Differ (2003) 1.08
Protective role of IgE in immunocompromised rat toxoplasmosis. J Immunol (1988) 1.07
Lipopeptides induce cell-mediated anti-HIV immune responses in seronegative volunteers. AIDS (2001) 1.06
Multi-drug resistant falciparum malaria in Cameroon in 1987-1988. II. Mefloquine resistance confirmed in vivo and in vitro and its correlation with quinine resistance. Am J Trop Med Hyg (1992) 1.05
Infection of B-cell-deficient mice by the parasite Schistosoma mansoni: demonstration of the participation of B cells in granuloma modulation. Scand J Immunol (1998) 1.05
High immunogenicity in chimpanzees of peptides and lipopeptides derived from four new Plasmodium falciparum pre-erythrocytic molecules. Vaccine (2000) 1.05
Cloning and sequencing of a 24-kDa Trypanosoma cruzi specific antigen released in association with membrane vesicles and defined by a monoclonal antibody. Biol Cell (1992) 1.05
Protective immunity in the rat model of congenital toxoplasmosis and the potential of excreted-secreted antigens as vaccine components. Parasite Immunol (1999) 1.04
In vitro and in vivo effects of interleukin 2 on the protozoan parasite leishmania. Eur J Immunol (1989) 1.04
The complete amino acid sequence of bovine milk angiogenin. FEBS Lett (1988) 1.03
Immune mechanisms underlying the premunition against Plasmodium falciparum malaria. Mem Inst Oswaldo Cruz (1994) 1.03
Protection of nude rats against Toxoplasma infection by excreted-secreted antigen-specific helper T cells. Infect Immun (1990) 1.03
New functions for platelets and their pathological implications. Int Arch Allergy Appl Immunol (1985) 1.03